Glenmede Trust CO Na Pacira Bio Sciences, Inc. Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $99,832 - $123,361	3,915 Added 1.08%	367,320 $10.5 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $731,667 - $937,168	26,414 Added 7.84%	363,405 $10.6 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $269,279 - $351,025	-10,231 Reduced 2.95%	336,991 $11.4 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $1.59 Million - $2.08 Million	51,877 Added 17.56%	347,222 $10.7 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $20,552 - $27,027	569 Added 0.19%	295,345 $11.8 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $4.04 Million - $4.93 Million	113,616 Added 62.72%	294,776 $12 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $854,004 - $1.28 Million	-22,362 Reduced 10.99%	181,160 $6.99 Million
Q3 2022 Nov 16, 2022	SELL	$51.24 - $58.89 $1.25 Million - $1.44 Million	-24,447 Reduced 10.72%	203,522 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $1.28 Million - $2.02 Million	-24,764 Reduced 9.8%	227,969 $13.3 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $3.24 Million - $4.12 Million	53,896 Added 27.11%	252,733 $19.3 Million
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $20,531 - $26,625	-428 Reduced 0.21%	198,837 $12 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $138,730 - $155,640	-2,539 Reduced 1.26%	199,265 $11.2 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $41,070 - $48,573	-694 Reduced 0.34%	201,804 $12.2 Million
Q1 2021 May 18, 2021	SELL	$59.31 - $78.82 $3.2 Million - $4.25 Million	-53,915 Reduced 21.03%	202,498 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $1.01 Million - $1.33 Million	-20,072 Reduced 7.26%	256,413 $15.3 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $2.98 Million - $3.61 Million	57,374 Added 26.18%	276,485 $16.6 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $6.68 Million - $11.4 Million	216,746 Added 9164.74%	219,111 $11.5 Million
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $297,269 - $383,397	-8,187 Reduced 77.59%	2,365 $107,000
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $312,381 - $394,112	8,760 Added 488.84%	10,552 $401,000
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $60,023 - $75,788	1,453 Added 428.61%	1,792 $77,000
Q2 2018 Aug 15, 2018	BUY	$27.5 - $39.8 $5,335 - $7,721	194 Added 133.79%	339 $11,000
Q4 2017 Feb 15, 2018	BUY	$31.85 - $46.95 $2,102 - $3,098	66 Added 83.54%	145 $6,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $2,820 - $3,120	79	79 $0

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.5M

Call Options Held

1.03M

Put Options Held

139K

Black Rock Inc. New York, NY

8.01M
Shares

$208 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.26M
Shares

$137 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

3.26M
Shares

$84.8 Million
0.15% of portfolio
D. E. Shaw & Co., Inc. New York, NY

2.26M
Shares

$58.7 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.99M
Shares

$51.8 Million
0.06% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.19B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account